- Home
- XLO vs APT Comparison
XLO vs APT Comparison
Compare XLO & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- APT
- Stock Information
- Founded
- XLO 2016
- APT 1983
- Country
- XLO United States
- APT Canada
- Employees
- XLO N/A
- APT N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- XLO Health Care
- APT
- Exchange
- XLO Nasdaq
- APT Nasdaq
- Market Cap
- XLO 42.2M
- APT 50.5M
- IPO Year
- XLO 2021
- APT 1995
- Fundamental
- Price
- XLO $0.69
- APT $4.70
- Analyst Decision
- XLO Buy
- APT
- Analyst Count
- XLO 1
- APT 0
- Target Price
- XLO $4.00
- APT N/A
- AVG Volume (30 Days)
- XLO 950.0K
- APT 38.1K
- Earning Date
- XLO 08-07-2025
- APT 08-06-2025
- Dividend Yield
- XLO N/A
- APT N/A
- EPS Growth
- XLO N/A
- APT 2.28
- EPS
- XLO N/A
- APT 0.36
- Revenue
- XLO $9,274,000.00
- APT $58,180,000.00
- Revenue This Year
- XLO $300.08
- APT N/A
- Revenue Next Year
- XLO $1.87
- APT N/A
- P/E Ratio
- XLO N/A
- APT $13.17
- Revenue Growth
- XLO N/A
- APT N/A
- 52 Week Low
- XLO $0.62
- APT $4.06
- 52 Week High
- XLO $1.70
- APT $6.44
- Technical
- Relative Strength Index (RSI)
- XLO 42.49
- APT 54.21
- Support Level
- XLO $0.65
- APT $4.54
- Resistance Level
- XLO $0.70
- APT $4.72
- Average True Range (ATR)
- XLO 0.04
- APT 0.21
- MACD
- XLO -0.01
- APT -0.01
- Stochastic Oscillator
- XLO 19.51
- APT 35.21
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.